Cardinal Health, Inc. has posted an impressive adjusted EPS of $2.63 for the second quarter of fiscal 2026, surpassing the Zacks Consensus Estimate by 10%. The company's revenues reached $65.6 billion, a 22.4% increase from the previous year, driven by strong demand in its specialty medicine sector. This performance has led Cardinal Health to raise its fiscal 2026 adjusted EPS outlook to between $10.15 and $10.35, reflecting robust growth in a transforming healthcare market.
“Cardinal Health · posted · second-quarter fiscal 2026 adjusted EPS · $2.63”
“Cardinal Health · posted · Revenues · $65.6 billion”
“Cardinal Health · posted second-quarter fiscal 2026 adjusted EPS of · $2.63 · exceeding the Zacks Consensus Estimate by 10%”
“Cardinal Health · posted a second-quarter fiscal 2026 adjusted EPS of · $2.63 · exceeding the Zacks Consensus Estimate by 10%”
“Cardinal Health · posted · second-quarter fiscal 2026 adjusted EPS · $2.63”
“Cardinal Health · posted · second-quarter fiscal 2026 adjusted EPS · $2.63”
“Cardinal Health, Inc. · was trading at · $226.18 · as of February 25th”
“Cardinal Health, Inc. · operates as · a healthcare services and products company · in the United States and internationally”
“Cardinal Health, Inc. · reported revenue of · $64 billion · in its latest quarter”
“Cardinal Health, Inc. · had a revenue increase of · 22.4% · from $52.3 billion a year ago”
“Cardinal Health, Inc. · reported operating earnings of · $611 million · or $2.55 per share”
“Cardinal Health, Inc. · experienced an earnings increase of · 35.6% · from $460 million or $1.88 per share”